Skip to main content
Premium Trial:

Request an Annual Quote

Scott Walton

Scott Walton was appointed the CEO of Miraca Life Sciences, following Avista Capital Partners' acquisition of the anatomic pathology lab from Miraca Holdings. Walton most recently was president and CEO of pain medication monitoring firm Ameritox. Before that, he was an executive vice president at Laboratory Corporation of America, where he ran the company's esoteric business unit. He previously was LabCorp's head of strategic planning and corporate development, and its chief information officer.